AnazaoHealth Corporation announces its "Making It Bearable For Kids ™" Program for pediatric patients receiving I-123 MIBG doses.
Tampa, FL --(BUSINESS WIRE)—March 22, 2007— The Nuclear Medicine division of AnazaoHealth® Corporation compounds many preparations to deal with the pain of illness and difficult medical procedures. Today, the company is proud to announce a new program for the littlest patients in hospitals receiving I-123 MIBG, a preparation, used primarily to diagnosis the presence and location of neuroblastomas in children. AnazaoHealth Corporation’s ‘Making It Bearable For Kids Program™’ will present a 6 ½” teddy bear to each child patient receiving the I-123 MIBG doses for a little added comfort as he or she goes through diagnosis and treatment.
Neuroblastoma is a form of cancer that occurs in infants and young children. It is rarely found in children older than 10 years old. The cells of this cancer usually resemble very primitive developing nerve cells found in an embryo or fetus. MIBG (metaiodobenzylguanidine) is a biotracer that is combined with radioactive iodine to form either 123I-iobenguane metaiodobenzylguanidine, I-123 MIBG, or 131I-iobenguane metaiodobenzylguanidine, I-131 MIBG. The biotracer, MIBG, has a natural affinity and travels to certain parts of the body, phaeochromocytomas, neuroblastomas, and the nerves of the heart. It is combined with radioactive iodine so that the imaging camera will “pick it up” and an image will be produced.
“The teddy bears can be a crucial diversion tool,” said Samantha Platt, Director, Sales & Marketing at AnazaoHealth. “The children can be subjected to lengthy scans performed multiple days in a row, Ms. Platt noted, “and by providing the bears to the hospitals to distract, comfort and occupy the children during their imaging procedures, we may assist in decreasing their fears and encouraging a feeling of wellness.”
“We are extremely pleased to be able to continue our commitment to the hospital communities we work with and provide the teddy bears,” stated Kevin Boyd, RPh., Nuclear Pharmacy Manager of AnazaoHealth. “Monday through Wednesdays we receive prescriptions for I-123 MIBG and each dose for a child is sent with a bear. We thank the hospital staffs for ‘paying forward’ the bears to the patients in their time of need.”
About AnazaoHealth Corporation
AnazaoHealth, headquartered in Tampa, Florida, focuses on patient specific preparations serving the nuclear medicine and pain management markets, as well as providing drugs used in clinical trials. AnazaoHealth is organized around four prescription and service divisions: Nuclear Medicine, Brachytherapy, Custom Pharmacy, and Pain Management, which includes pre-filled cassettes of steroid injections, intrathecal pump refills and other innovative therapies. AnazaoHealth, in its 46,000 square foot facility in Tampa and a 5,500 square foot facility located in Amarillo, TX, specializes in compounding sterile preparations and is fully licensed to provide nuclear, radioactive materials and DEA controlled substances in all 50 states, the District of Columbia and Puerto Rico. Visit the AnazaoHealth web site at www.anazaohealth.com.